10 20 30 40 50 60 70 80 3P33 - Header ----|----|----|----|----|----|----|----|----|----|----|----|----|----|----|----| Asymmetric UnitHEADER HORMONE 04-OCT-10 3P33
TITLE INSULIN FIBRILLATION IS THE JANUS FACE OF INDUCED FIT. A CHIRAL CLAMP TITLE 2 STABILIZES THE NATIVE STATE AT THE EXPENSE OF ACTIVITY
COMPND MOL_ID: 1; COMPND 2 MOLECULE: INSULIN; COMPND 3 CHAIN: A, C, E, G; COMPND 4 FRAGMENT: UNP RESIDUES 90-110; COMPND 5 SYNONYM: INSULIN A CHAIN; COMPND 6 ENGINEERED: YES; COMPND 7 MOL_ID: 2; COMPND 8 MOLECULE: INSULIN; COMPND 9 CHAIN: B, D, F, H; COMPND 10 FRAGMENT: UNP RESIDUES 25-54; COMPND 11 SYNONYM: INSULIN B CHAIN; COMPND 12 ENGINEERED: YES
SOURCE MOL_ID: 1; SOURCE 2 SYNTHETIC: YES; SOURCE 3 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 4 ORGANISM_COMMON: HUMAN; SOURCE 5 ORGANISM_TAXID: 9606; SOURCE 6 MOL_ID: 2; SOURCE 7 SYNTHETIC: YES; SOURCE 8 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 9 ORGANISM_COMMON: HUMAN; SOURCE 10 ORGANISM_TAXID: 9606
KEYWDS ZINC-BINDING SITE, LONG-ACTING INSULIN ANALOG, RECEPTOR BINDING KEYWDS 2 PROTEIN ENGINEERING, GLOBAL HEALTH, INSULIN FIBRILLATION, HORMONE
EXPDTA X-RAY DIFFRACTION
AUTHOR Q.X.HUA,Z.L.WAN,K.HUANG,S.Q.HU,N.F.PHILLIP,W.H.JIA,J.WHITTINGHAM, AUTHOR 2 G.G.DODSON,P.G.KATSOYANNIS,M.A.WEISS
REVDAT 3 15-OCT-14 3P33 1 REMARK REVDAT 2 08-OCT-14 3P33 1 AUTHOR REVDAT 1 23-NOV-11 3P33 0
JRNL AUTH Q.X.HUA,Z.L.WAN,K.HUANG,S.Q.HU,N.F.PHILLIP,W.H.JIA, JRNL AUTH 2 J.WHITTINGHAM,G.G.DODSON,P.G.KATSOYANNIS,M.A.WEISS JRNL TITL INSULIN FIBRILLATION IS THE JANUS FACE OF INDUCED FIT. A JRNL TITL 2 CHIRAL CLAMP STABILIZES THE NATIVE STATE AT THE EXPENSE OF JRNL TITL 3 ACTIVITY JRNL REF TO BE PUBLISHED JRNL REFN
REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH Z.L.WAN,K.HUANG,B.XU,S.Q.HU,S.WANG,Y.C.CHU,P.G.KATSOYANNIS, REMARK 1 AUTH 2 M.A.WEISS REMARK 1 TITL DIABETES-ASSOCIATED MUTATIONS IN HUMAN INSULIN: CRYSTAL REMARK 1 TITL 2 STRUCTURE AND PHOTO-CROSS-LINKING STUDIES OF A-CHAIN VARIANT REMARK 1 TITL 3 INSULIN WAKAYAMA. REMARK 1 REF BIOCHEMISTRY V. 44 5000 2005 REMARK 1 REFN ISSN 0006-2960 REMARK 1 PMID 15794638 REMARK 1 DOI 10.1021/BI047585K REMARK 1 REFERENCE 2 REMARK 1 AUTH Z.L.WAN,B.XU,Y.C.CHU,P.G.KATSOYANNIS,M.A.WEISS REMARK 1 TITL CRYSTAL STRUCTURE OF ALLO-ILE(A2)-INSULIN, AN INACTIVE REMARK 1 TITL 2 CHIRAL ANALOGUE: IMPLICATIONS FOR THE MECHANISM OF RECEPTOR REMARK 1 TITL 3 BINDING REMARK 1 REF BIOCHEMISTRY V. 42 12770 2003 REMARK 1 REFN ISSN 0006-2960 REMARK 1 PMID 14596591 REMARK 1 DOI 10.1021/BI034430O REMARK 1 REFERENCE 3 REMARK 1 AUTH Z.L.WAN,B.XU,Y.C.CHU,B.LI,S.H.NAKAGAWA,Y.QU,S.Q.HU, REMARK 1 AUTH 2 P.G.KATSOYANNIS,M.A.WEISS REMARK 1 TITL ENHANCING THE ACTIVITY OF INSULIN AT THE RECEPTOR INTERFACE: REMARK 1 TITL 2 CRYSTAL STRUCTURE AND PHOTO-CROSS-LINKING OF A8 ANALOGUES. REMARK 1 REF BIOCHEMISTRY V. 43 16119 2004 REMARK 1 REFN ISSN 0006-2960 REMARK 1 PMID 15610006 REMARK 1 DOI 10.1021/BI048223F REMARK 1 REFERENCE 4 REMARK 1 AUTH E.N.BAKER,T.L.BLUNDELL,J.F.CUTFIELD,S.M.CUTFIELD,E.J.DODSON, REMARK 1 AUTH 2 G.G.DODSON,D.HODGKIN,N.W.ISAACS,C.D.REYNOLDS REMARK 1 TITL THE STRUCTURE OF 2ZN PIG INSULIN CRYSTAL AT 1.5 A RESOLUTION REMARK 1 REF PHILOS.TRANS.R.SOC.LONDON, V. 319 369 1988 REMARK 1 REF 2 SER.B REMARK 1 REFN ISSN 0080-4622 REMARK 1 PMID 2905485 REMARK 1 DOI 10.1098/RSTB.1988.0058 REMARK 1 REFERENCE 5 REMARK 1 AUTH G.BENTLEY,E.DODSON,G.DODSON,D.HODGKIN,D.MERCOLA REMARK 1 TITL STRUCTURE OF INSULIN IN 4-ZINC INSULIN REMARK 1 REF NATURE V. 261 166 1976 REMARK 1 REFN ISSN 0028-0836 REMARK 1 PMID 1272390 REMARK 1 REFERENCE 6 REMARK 1 AUTH U.DEREWENDA,Z.DEREWENDA,E.DODSON,G.DODSON,C.REYNOLD,G.SMITH, REMARK 1 AUTH 2 C.SPARKS,D.SWENSON REMARK 1 TITL PHENOL STABILIZES MORE HELIX IN A NEW SYMMETRICAL ZINC REMARK 1 TITL 2 INSULIN HEXAMER REMARK 1 REF NATURE V. 338 594 1989 REMARK 1 REFN ISSN 0028-0836 REMARK 1 PMID 2648161 REMARK 1 DOI 10.1038/338594A0
REMARK 2 REMARK 2 RESOLUTION. 2.30 ANGSTROMS.
REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : ENGH & HUBER REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.30 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 51.11 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : NULL REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 90.2 REMARK 3 NUMBER OF REFLECTIONS : 7098 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.214 REMARK 3 FREE R VALUE : 0.299 REMARK 3 FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 FREE R VALUE TEST SET COUNT : 733 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : NULL REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.30 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.44 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 76.70 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : NULL REMARK 3 BIN R VALUE (WORKING SET) : 0.2400 REMARK 3 BIN FREE R VALUE : 0.3360 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 BIN FREE R VALUE TEST SET COUNT : 113 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.032 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 1620 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 36 REMARK 3 SOLVENT ATOMS : 90 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 31.20 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 47.30 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 4.14000 REMARK 3 B22 (A**2) : 4.14000 REMARK 3 B33 (A**2) : -8.28000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.28 REMARK 3 ESD FROM SIGMAA (A) : 0.23 REMARK 3 LOW RESOLUTION CUTOFF (A) : 5.00 REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM C-V SIGMAA (A) : NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : NULL REMARK 3 BOND ANGLES (DEGREES) : 1.200 REMARK 3 DIHEDRAL ANGLES (DEGREES) : 19.700 REMARK 3 IMPROPER ANGLES (DEGREES) : 0.700 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : RESTRAINED REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : NULL REMARK 3 KSOL : NULL REMARK 3 BSOL : NULL REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : NULL REMARK 3 TOPOLOGY FILE 1 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL
REMARK 4 REMARK 4 3P33 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11
REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 05-OCT-10. REMARK 100 THE RCSB ID CODE IS RCSB061894.
REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 14-JAN-05 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 8.3 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : BRUKER AXS MICROSTAR REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.5418 REMARK 200 MONOCHROMATOR : GRAPHITE REMARK 200 OPTICS : MIRRORS REMARK 200 REMARK 200 DETECTOR TYPE : NULL REMARK 200 DETECTOR MANUFACTURER : NULL REMARK 200 INTENSITY-INTEGRATION SOFTWARE : PROTEUM REMARK 200 DATA SCALING SOFTWARE : PROTEUM REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 10019 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.300 REMARK 200 RESOLUTION RANGE LOW (A) : 51.110 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 96.9 REMARK 200 DATA REDUNDANCY : 4.410 REMARK 200 R MERGE (I) : 0.06300 REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 7.3700 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.30 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.44 REMARK 200 COMPLETENESS FOR SHELL (%) : 76.7 REMARK 200 DATA REDUNDANCY IN SHELL : 4.80 REMARK 200 R MERGE FOR SHELL (I) : 0.26500 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : 7.700 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: CNS REMARK 200 STARTING MODEL: PDB ENTRY 1XDA REMARK 200 REMARK 200 REMARK: NULL
REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 37.40 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 1.96 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.05 M SODIUM CITRATE, 1% PHENOL, REMARK 280 0.04% ZINC ACETATE, PH 8.3, VAPOR DIFFUSION, HANGING DROP, REMARK 280 TEMPERATURE 298K
REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: H 3 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -Y,X-Y,Z REMARK 290 3555 -X+Y,-X,Z REMARK 290 4555 X+2/3,Y+1/3,Z+1/3 REMARK 290 5555 -Y+2/3,X-Y+1/3,Z+1/3 REMARK 290 6555 -X+Y+2/3,-X+1/3,Z+1/3 REMARK 290 7555 X+1/3,Y+2/3,Z+2/3 REMARK 290 8555 -Y+1/3,X-Y+2/3,Z+2/3 REMARK 290 9555 -X+Y+1/3,-X+2/3,Z+2/3 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 2 0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 3 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 3 -0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 38.95000 REMARK 290 SMTRY2 4 0.000000 1.000000 0.000000 22.48779 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 26.10000 REMARK 290 SMTRY1 5 -0.500000 -0.866025 0.000000 38.95000 REMARK 290 SMTRY2 5 0.866025 -0.500000 0.000000 22.48779 REMARK 290 SMTRY3 5 0.000000 0.000000 1.000000 26.10000 REMARK 290 SMTRY1 6 -0.500000 0.866025 0.000000 38.95000 REMARK 290 SMTRY2 6 -0.866025 -0.500000 0.000000 22.48779 REMARK 290 SMTRY3 6 0.000000 0.000000 1.000000 26.10000 REMARK 290 SMTRY1 7 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 7 0.000000 1.000000 0.000000 44.97559 REMARK 290 SMTRY3 7 0.000000 0.000000 1.000000 52.20000 REMARK 290 SMTRY1 8 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 8 0.866025 -0.500000 0.000000 44.97559 REMARK 290 SMTRY3 8 0.000000 0.000000 1.000000 52.20000 REMARK 290 SMTRY1 9 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 9 -0.866025 -0.500000 0.000000 44.97559 REMARK 290 SMTRY3 9 0.000000 0.000000 1.000000 52.20000 REMARK 290 REMARK 290 REMARK: NULL
REMARK 300 REMARK 300 BIOMOLECULE: 1, 2, 3, 4 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA.
REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: HEXAMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: HEXAMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 5610 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 11070 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -154.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 2 -0.500000 -0.866025 0.000000 0.00000 REMARK 350 BIOMT2 2 0.866025 -0.500000 0.000000 0.00000 REMARK 350 BIOMT3 2 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 3 -0.500000 0.866025 0.000000 0.00000 REMARK 350 BIOMT2 3 -0.866025 -0.500000 0.000000 0.00000 REMARK 350 BIOMT3 3 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: HEXAMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: HEXAMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 5550 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 11510 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -158.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: C, D REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 2 -0.500000 -0.866025 0.000000 0.00000 REMARK 350 BIOMT2 2 0.866025 -0.500000 0.000000 0.00000 REMARK 350 BIOMT3 2 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 3 -0.500000 0.866025 0.000000 0.00000 REMARK 350 BIOMT2 3 -0.866025 -0.500000 0.000000 0.00000 REMARK 350 BIOMT3 3 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 3 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: HEXAMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: HEXAMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 6200 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 10220 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -150.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: E, F REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 2 -0.500000 -0.866025 0.000000 0.00000 REMARK 350 BIOMT2 2 0.866025 -0.500000 0.000000 0.00000 REMARK 350 BIOMT3 2 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 3 -0.500000 0.866025 0.000000 0.00000 REMARK 350 BIOMT2 3 -0.866025 -0.500000 0.000000 0.00000 REMARK 350 BIOMT3 3 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 4 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: HEXAMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: HEXAMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 5860 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 10880 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -146.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: G, H REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 2 -0.500000 -0.866025 0.000000 0.00000 REMARK 350 BIOMT2 2 0.866025 -0.500000 0.000000 0.00000 REMARK 350 BIOMT3 2 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 3 -0.500000 0.866025 0.000000 0.00000 REMARK 350 BIOMT2 3 -0.866025 -0.500000 0.000000 0.00000 REMARK 350 BIOMT3 3 0.000000 0.000000 1.000000 0.00000
REMARK 375 REMARK 375 SPECIAL POSITION REMARK 375 THE FOLLOWING ATOMS ARE FOUND TO BE WITHIN 0.15 ANGSTROMS REMARK 375 OF A SYMMETRY RELATED ATOM AND ARE ASSUMED TO BE ON SPECIAL REMARK 375 POSITIONS. REMARK 375 REMARK 375 ATOM RES CSSEQI REMARK 375 ZN ZN B 31 LIES ON A SPECIAL POSITION. REMARK 375 CL CL B 32 LIES ON A SPECIAL POSITION. REMARK 375 ZN ZN D 31 LIES ON A SPECIAL POSITION. REMARK 375 CL CL D 32 LIES ON A SPECIAL POSITION. REMARK 375 ZN ZN F 31 LIES ON A SPECIAL POSITION. REMARK 375 CL CL F 32 LIES ON A SPECIAL POSITION. REMARK 375 ZN ZN H 31 LIES ON A SPECIAL POSITION. REMARK 375 CL CL H 32 LIES ON A SPECIAL POSITION.
REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 LYS B 29 157.27 -40.53 REMARK 500 LYS H 29 97.08 -11.20 REMARK 500 REMARK 500 REMARK: NULL
REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ZN B 31 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CL B 32 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ZN D 31 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CL D 32 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ZN F 31 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CL F 32 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC7 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ZN H 31 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC8 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CL H 32 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC9 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE IPH A 100 REMARK 800 REMARK 800 SITE_IDENTIFIER: BC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE IPH C 200 REMARK 800 REMARK 800 SITE_IDENTIFIER: BC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE IPH E 300 REMARK 800 REMARK 800 SITE_IDENTIFIER: BC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE IPH G 400
REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1XDA RELATED DB: PDB REMARK 900 R'R STATE INSULIN CRYSTAL STRUCTURE REMARK 900 RELATED ID: 3P2X RELATED DB: PDB
DBREF 3P33 A 1 21 UNP P01308 INS_HUMAN 90 110 DBREF 3P33 B 1 30 UNP P01308 INS_HUMAN 25 54 DBREF 3P33 C 1 21 UNP P01308 INS_HUMAN 90 110 DBREF 3P33 D 1 30 UNP P01308 INS_HUMAN 25 54 DBREF 3P33 E 1 21 UNP P01308 INS_HUMAN 90 110 DBREF 3P33 F 1 30 UNP P01308 INS_HUMAN 25 54 DBREF 3P33 G 1 21 UNP P01308 INS_HUMAN 90 110 DBREF 3P33 H 1 30 UNP P01308 INS_HUMAN 25 54
SEQRES 1 A 21 GLY ILE VAL GLU GLN CYS CYS THR SER ILE CYS SER LEU SEQRES 2 A 21 TYR GLN LEU GLU ASN TYR CYS ASN SEQRES 1 B 30 PHE VAL ASN GLN HIS LEU CYS GLY SER HIS LEU VAL GLU SEQRES 2 B 30 ALA LEU TYR LEU VAL CYS GLY GLU ARG GLY PHE PHE TYR SEQRES 3 B 30 THR PRO LYS THR SEQRES 1 C 21 GLY ILE VAL GLU GLN CYS CYS THR SER ILE CYS SER LEU SEQRES 2 C 21 TYR GLN LEU GLU ASN TYR CYS ASN SEQRES 1 D 30 PHE VAL ASN GLN HIS LEU CYS GLY SER HIS LEU VAL GLU SEQRES 2 D 30 ALA LEU TYR LEU VAL CYS GLY GLU ARG GLY PHE PHE TYR SEQRES 3 D 30 THR PRO LYS THR SEQRES 1 E 21 GLY ILE VAL GLU GLN CYS CYS THR SER ILE CYS SER LEU SEQRES 2 E 21 TYR GLN LEU GLU ASN TYR CYS ASN SEQRES 1 F 30 PHE VAL ASN GLN HIS LEU CYS GLY SER HIS LEU VAL GLU SEQRES 2 F 30 ALA LEU TYR LEU VAL CYS GLY GLU ARG GLY PHE PHE TYR SEQRES 3 F 30 THR PRO LYS THR SEQRES 1 G 21 GLY ILE VAL GLU GLN CYS CYS THR SER ILE CYS SER LEU SEQRES 2 G 21 TYR GLN LEU GLU ASN TYR CYS ASN SEQRES 1 H 30 PHE VAL ASN GLN HIS LEU CYS GLY SER HIS LEU VAL GLU SEQRES 2 H 30 ALA LEU TYR LEU VAL CYS GLY GLU ARG GLY PHE PHE TYR SEQRES 3 H 30 THR PRO LYS THR
HET IPH A 100 7 HET ZN B 31 1 HET CL B 32 1 HET IPH C 200 7 HET ZN D 31 1 HET CL D 32 1 HET IPH E 300 7 HET ZN F 31 1 HET CL F 32 1 HET IPH G 400 7 HET ZN H 31 1 HET CL H 32 1
HETNAM IPH PHENOL HETNAM ZN ZINC ION HETNAM CL CHLORIDE ION
FORMUL 9 IPH 4(C6 H6 O) FORMUL 10 ZN 4(ZN 2+) FORMUL 11 CL 4(CL 1-) FORMUL 21 HOH *90(H2 O)
HELIX 1 1 GLY A 1 CYS A 7 1 7 HELIX 2 2 SER A 12 ASN A 18 1 7 HELIX 3 3 PHE B 1 GLY B 20 1 20 HELIX 4 4 GLU B 21 GLY B 23 5 3 HELIX 5 5 GLY C 1 CYS C 7 1 7 HELIX 6 6 SER C 12 ASN C 18 1 7 HELIX 7 7 PHE D 1 GLY D 20 1 20 HELIX 8 8 GLU D 21 GLY D 23 5 3 HELIX 9 9 GLY E 1 CYS E 6 1 6 HELIX 10 10 SER E 12 ASN E 18 1 7 HELIX 11 11 VAL F 2 GLY F 20 1 19 HELIX 12 12 GLU F 21 GLY F 23 5 3 HELIX 13 13 GLY G 1 CYS G 7 1 7 HELIX 14 14 SER G 12 ASN G 18 1 7 HELIX 15 15 PHE H 1 GLY H 20 1 20 HELIX 16 16 GLU H 21 GLY H 23 5 3
SHEET 1 A 2 PHE B 24 TYR B 26 0 SHEET 2 A 2 PHE D 24 TYR D 26 -1 O TYR D 26 N PHE B 24 SHEET 1 B 2 PHE F 24 TYR F 26 0 SHEET 2 B 2 PHE H 24 TYR H 26 -1 O PHE H 24 N TYR F 26
SSBOND 1 CYS A 6 CYS A 11 1555 1555 2.03 SSBOND 2 CYS A 7 CYS B 7 1555 1555 2.04 SSBOND 3 CYS A 20 CYS B 19 1555 1555 2.03 SSBOND 4 CYS C 6 CYS C 11 1555 1555 2.03 SSBOND 5 CYS C 7 CYS D 7 1555 1555 2.04 SSBOND 6 CYS C 20 CYS D 19 1555 1555 2.03 SSBOND 7 CYS E 6 CYS E 11 1555 1555 2.03 SSBOND 8 CYS E 7 CYS F 7 1555 1555 2.04 SSBOND 9 CYS E 20 CYS F 19 1555 1555 2.03 SSBOND 10 CYS G 6 CYS G 11 1555 1555 2.03 SSBOND 11 CYS G 7 CYS H 7 1555 1555 2.04 SSBOND 12 CYS G 20 CYS H 19 1555 1555 2.03
LINK NE2 HIS F 10 ZN ZN F 31 1555 1555 2.03 LINK NE2 HIS H 10 ZN ZN H 31 1555 1555 2.04 LINK NE2 HIS D 10 ZN ZN D 31 1555 1555 2.08 LINK NE2 HIS B 10 ZN ZN B 31 1555 1555 2.08
SITE 1 AC1 2 HIS B 10 CL B 32 SITE 1 AC2 2 HIS B 10 ZN B 31 SITE 1 AC3 2 HIS D 10 CL D 32 SITE 1 AC4 2 HIS D 10 ZN D 31 SITE 1 AC5 2 HIS F 10 CL F 32 SITE 1 AC6 2 HIS F 10 ZN F 31 SITE 1 AC7 2 HIS H 10 CL H 32 SITE 1 AC8 2 HIS H 10 ZN H 31 SITE 1 AC9 5 CYS A 6 SER A 9 ILE A 10 CYS A 11 SITE 2 AC9 5 LEU B 11 SITE 1 BC1 4 CYS C 6 SER C 9 CYS C 11 HIS D 10 SITE 1 BC2 6 CYS E 6 SER E 9 ILE E 10 CYS E 11 SITE 2 BC2 6 HIS F 5 LEU F 11 SITE 1 BC3 7 CYS G 6 SER G 9 ILE G 10 CYS G 11 SITE 2 BC3 7 HIS H 5 HIS H 10 LEU H 11
CRYST1 77.900 77.900 78.300 90.00 90.00 120.00 H 3 36
ORIGX1 1.000000 0.000000 0.000000 0.00000
ORIGX2 0.000000 1.000000 0.000000 0.00000
ORIGX3 0.000000 0.000000 1.000000 0.00000
SCALE1 0.012837 0.007411 0.000000 0.00000
SCALE2 0.000000 0.014823 0.000000 0.00000
SCALE3 0.000000 0.000000 0.012771 0.00000